Traders Sell UnitedHealth Group (UNH) on Strength (UNH)

Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading hours on Tuesday. $342.45 million flowed into the stock on the tick-up and $419.71 million flowed out of the stock on the tick-down, for a money net flow of $77.26 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 11th highest net out-flow for the day. UnitedHealth Group traded up $4.26 for the day and closed at $232.90

Several research firms have issued reports on UNH. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday, September 21st. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $210.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 10th. Jefferies Group increased their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Friday, October 13th. Finally, BMO Capital Markets began coverage on UnitedHealth Group in a research report on Monday, October 16th. They issued an “outperform” rating and a $250.00 price objective for the company. Three investment analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $229.54.

The stock has a market capitalization of $225,180.00, a PE ratio of 26.47, a price-to-earnings-growth ratio of 1.54 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter last year, the business posted $2.11 earnings per share. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. research analysts anticipate that UnitedHealth Group Inc will post 9.99 earnings per share for the current year.

In other news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the transaction, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,630 shares of company stock valued at $7,669,416. Company insiders own 0.89% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Regal Wealth Group Inc. increased its position in UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after purchasing an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. increased its position in UnitedHealth Group by 0.4% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after purchasing an additional 4 shares in the last quarter. RB Capital Management LLC increased its position in UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after purchasing an additional 7 shares in the last quarter. RNC Capital Management LLC increased its position in UnitedHealth Group by 0.7% during the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $360,000 after purchasing an additional 13 shares in the last quarter. Finally, Highland Private Wealth Management increased its position in UnitedHealth Group by 0.4% during the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock worth $593,000 after purchasing an additional 13 shares in the last quarter. Institutional investors and hedge funds own 86.09% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another website, it was stolen and reposted in violation of United States & international trademark & copyright law. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/01/16/traders-sell-unitedhealth-group-unh-on-strength-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply